Curative Effect Analysis of Combination of Anti-Cancer Qinghuang Decoction and Hydroxyurea Tablets in Treatment of Chronic Myeloid Leukemia
Objective To observe curative effect of anti-cancer Qinghuang decoction and hydroxyurea tablets on patients with chronic myeloid leukemia.Methods The paper chose patients with chronic myeloid leukemia from March 2021 to May 2023,and divided them into two groups randomly.Control group was treated with hydroxyurea tablets,while experimental group with hydroxyurea tablets and anti-cancer Qinghuang decoction.Treatment effect,safety,serological indicators,and symptom change scores were compared.Results There was no statistically significant difference in levels of immature granulocytes,white blood cell count,and symptom changes in bone marrow between experimental group and control group,with P>0.05.Changes in symptoms,levels of immature granulocytes in bone marrow,and white blood cell count in experimental group were better than control group.Safety and effect of experimental group was better than control group,with P<0.05.Conclusion Hydroxyurea tablets and anti-cancer Qinghuang decoction can improve effect and safety of disease control,discomfort symptoms early,control the level of inflammatory factors,and improve life quality of chronic myeloid leukemia patients.
Anti cancer Qinghuang decoctionHydroxyurea tabletsChronic myeloid leukemiaClinical effectSafety
万方数据
维普
